Tauopathies: Structural Basis of Protein Pathology

Tauopathies are neurodegenerative disorders caused due to misfolding and aggregation of the tau protein in neurofibrillary tangles in the brain. This feed focuses on the structural basis of protein pathology in tauopathies. Here is the latest research.

January 16, 2022

A kinetic scheme to examine the role of glial cells in the pathogenesis of Alzheimer's disease.

Metabolic Brain Disease
R A Thuraisingham
January 16, 2022
Review

A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities.

Ageing Research Reviews
Siva Prasad Panda, Urvashi Soni
January 15, 2022
Case Report

Diffuse Lewy body disease presenting as Parkinson's disease with progressive aphasia.

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Shunsuke KogaDennis W Dickson
January 14, 2022

Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers.

Brain : a Journal of Neurology
Claire BridelSebastiaan Engelborghs
January 14, 2022

Fukutin regulates tau phosphorylation and synaptic function: Novel properties of fukutin in neurons.

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Ryota TsukuiNoriyuki Shibata
January 14, 2022

Braiding Braak and Braak: Staging patterns and model selection in network neurodegeneration.

Network Neuroscience
Prama PutraAlain Goriely
January 14, 2022
Review

Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis.

Neurotoxicity Research
Hamed Kazemi Shariat PanahiVanessa X Tan
January 13, 2022
Review

Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease.

Neural Regeneration Research
Alejandro R RodaSandra Villegas
January 13, 2022

Aluminium Induced Neurodegeneration in Rat Cerebellum in the Presence of Ethanol Coexposure.

Journal of Pharmacy & Bioallied Sciences
Buddhadeb GhoshSuman Yadav
January 12, 2022
Review
Open Access

Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer's Disease Proteinopathy.

International Journal of Molecular Sciences
Ryszard PlutaStanisław J Czuczwar
January 12, 2022
Review
Open Access

Roles and Mechanisms of the Protein Quality Control System in Alzheimer's Disease.

International Journal of Molecular Sciences
Yaping LiuXing Li
January 12, 2022
Open Access

Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1α: Therapeutic Implication in Alzheimer's Disease.

International Journal of Molecular Sciences
Laura BonfiliAnna Maria Eleuteri
January 12, 2022
Review

Probiotics for Alzheimer's Disease: A Systematic Review.

Nutrients
Ruth NaomiHasnah Bahari
January 12, 2022

Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease.

Nature Communications
Yun YangGary E Gibson
January 12, 2022
Review

Neurotrophic factors in Alzheimer's disease: pathogenesis and therapy.

Acta Neurobiologiae Experimentalis
Joachim Hr LübkeAkram Sadeghi
January 10, 2022

Biochemical and biophysical features of disease-associated tau mutants V363A and V363I.

Biochimica Et Biophysica Acta. Proteins and Proteomics
Ada De LuigiMario Salmona

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved
/feed-previews/tauopathies-structural-basis-of-protein/0606fdb8-76a2-4d13-b97a-de2853b3b855